Monte Rosa Therapeutics, Inc.
← Back to GLUE Overview

Monte Rosa Therapeutics, Inc. (GLUE)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-6.05

Financial Fundamentals

GLUEQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2020-03-31-26.47
2020-06-30-21.18
2020-09-30-17.65
2020-12-31-5.88
2021-03-31-18.26
2021-06-30-1.56
2021-09-30-12.95
2021-12-31-10.01
2022-03-31-6.87
2022-06-30-4.40
2022-09-30-3.65
2022-12-31-3.22
2023-03-31-3.25
2023-06-30-2.41
2023-09-30-1.71
2023-12-31-2.44
2024-03-31-3.37
2024-06-30-2.29
2024-09-30-4.57
2024-12-317.89
2025-03-312.04
2025-06-30-7.52
2025-09-30-5.61
2025-12-31-5.60
2026-03-31-6.05

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.